Issue 14, 2021

Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy

Abstract

Gastrectomy is the main treatment for gastric cancer (GC) at present. Surgery improves the survival rate of patients, but the complications seriously affect the recovery and lack effective treatment measures. In the present study, probiotic compounds (4 strains; Lactobacillus plantarum MH-301 (CGMCC NO. 18618), L. rhamnosus LGG-18 (CGMCC NO. 14007), L. acidophilus and Bifidobacterium animalis subsp.lactis LPL-RH (CGMCC NO. 4599)), through clinical and animal model verification, were studied to try to find the auxiliary treatment measures after gastrectomy, and explore its potential mechanism. Clinical research results showed that probiotic compounds treatment could significantly lower postoperative inflammation, enhance immunity, resume gut microbiota composition and promote postoperative recovery. The results in rat models indicated that gastrostomy led to the aggravation of inflammation, the impairment of immunity and intestinal barrier, and the disorder of gut microbiota in vivo. Furthermore, probiotic compounds’ administration could downregulate the inflammatory and permeability signaling pathways in the intestinal tissue, reduce the levels of proinflammatory factors, maintain the intestinal mucosal barrier and immune function, and recover the disorder of gut microbiota after gastrectomy in rats. Therefore, we conclude that probiotic compounds can restore gut microbiota homeostasis, reduce inflammation, maintain intestinal mucosal barrier and immunity, finally promote recovery after gastrectomy, and is expected to improve the prognosis of patients.

Graphical abstract: Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy

Supplementary files

Article information

Article type
Paper
Submitted
02 May 2021
Accepted
14 May 2021
First published
14 May 2021

Food Funct., 2021,12, 6294-6308

Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy

C. Zheng, T. Chen, J. Lu, K. Wei, H. Tian, W. Liu, T. Xu, X. Wang, S. Wang, R. Yang, Y. Yang, Z. Liu, H. Wei and X. Deng, Food Funct., 2021, 12, 6294 DOI: 10.1039/D1FO01375K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements